Skip to menu Skip to content Skip to footer

2025

Journal Article

A Phase 2b, open-label, single arm, multicentre, pilot study of the efficacy, safety and tolerability of dostarlimab in women with early-stage MMR deficient endometrioid endometrial adenocarcinoma

Obermair, A., Gebski, V., Goh, J., Kuchel, A., Brand, A., Mak, B., McNally, O., Baxter, E., Jobling, T. and Mileshkin, L. (2025). A Phase 2b, open-label, single arm, multicentre, pilot study of the efficacy, safety and tolerability of dostarlimab in women with early-stage MMR deficient endometrioid endometrial adenocarcinoma. International Journal of Gynecological Cancer 101644, 101644. doi: 10.1016/j.ijgc.2025.101644

A Phase 2b, open-label, single arm, multicentre, pilot study of the efficacy, safety and tolerability of dostarlimab in women with early-stage MMR deficient endometrioid endometrial adenocarcinoma

2021

Journal Article

A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer – ENDO-3: ANZGOG trial 1911/2020

Obermair, Andreas, Nicklin, Jim, Gebski, Val, Hayes, Sandra C., Graves, Nicholas, Mileshkin, Linda, Lin, Ming Yin, Beale, Phillip, Baxter, Eva, Robledo, Kristy, Salomon, Carlos, Hanna, George B. and Janda, Monika (2021). A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer – ENDO-3: ANZGOG trial 1911/2020. International Journal of Gynecologic Cancer, 31 (12) ijgc-2021-003029, 1595-1601. doi: 10.1136/ijgc-2021-003029

A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer – ENDO-3: ANZGOG trial 1911/2020

2020

Journal Article

Fertility-sparing treatment in early endometrial cancer: current state and future strategies

Obermair, Andreas, Baxter, Eva, Brennan, Donal J., McAlpine, Jessica N., Muellerer, Jennifer J., Amant, Frédéric, van Gent, Mignon D. J. M., Coleman, Robert L., Westin, Shannon N., Yates, Melinda S., Krakstad, Camilla and Janda, Monika (2020). Fertility-sparing treatment in early endometrial cancer: current state and future strategies. Obstetrics and Gynecology Science, 63 (4), 417-431. doi: 10.5468/ogs.19169

Fertility-sparing treatment in early endometrial cancer: current state and future strategies

2020

Journal Article

Improving response to progestin treatment of low-grade endometrial cancer

Baxter, Eva, Brennan, Donal J, McAlpine, Jessica N, Mueller, Jennifer J, Amant, Frédéric, van Gent, Mignon D J M, Huntsman, David G, Coleman, Robert L, Westin, Shannon N, Yates, Melinda S, Krakstad, Camilla, Quinn, Michael A, Janda, Monika and Obermair, Andreas (2020). Improving response to progestin treatment of low-grade endometrial cancer. International Journal of Gynecologic Cancer, 30 (11) ijgc-2020-001309, ijgc-2020. doi: 10.1136/ijgc-2020-001309

Improving response to progestin treatment of low-grade endometrial cancer

2020

Journal Article

Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer

Donohoe, Fionán, Wilkinson, Michael, Baxter, Eva and Brennan, Donal J. (2020). Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer. International Journal of Molecular Sciences, 21 (4) 1241, 1-19. doi: 10.3390/ijms21041241

Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer

2020

Journal Article

G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome

Casciello, Francesco, Al-Ejeh, Fares, Miranda, Mariska, Kelly, Greg, Baxter, Eva, Windloch, Karolina, Gannon, Frank and Lee, Jason S. (2020). G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome. Theranostics, 10 (10), 4515-4529. doi: 10.7150/thno.41453

G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome

2019

Journal Article

Molecular basis of distinct oestrogen responses in endometrial and breast cancer

Baxter, Eva, Windloch, Karolina, Kelly, Greg, Lee, Jason S., Gannon, Frank and Brennan, Donal (2019). Molecular basis of distinct oestrogen responses in endometrial and breast cancer. Endocrine-Related Cancer, 26 (1), 31-46. doi: 10.1530/ERC-17-0563

Molecular basis of distinct oestrogen responses in endometrial and breast cancer

2018

Journal Article

Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation

Jacquelin, Sebastien, Straube, Jasmin, Cooper, Leanne, Vu, Therese, Song, Axia, Bywater, Megan, Baxter, Eva, Heidecker, Matthew, Wackrow, Brad, Porter, Amy, Ling, Victoria, Green, Joanne, Austin, Rebecca, Kazakoff, Stephen, Waddell, Nicola, Hesson, Luke B., Pimanda, John E., Stegelmann, Frank, Bullinger, Lars, Döhner, Konstanze, Rampal, Raajit K., Heckl, Dirk, Hill, Geoffrey R. and Lane, Steven W. (2018). Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation. Blood, 132 (26), blood-2018. doi: 10.1182/blood-2018-04-846220

Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation

2016

Journal Article

Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy

Obermair, Andreas, Brennan, Donal J., Baxter, Eva, Armes, Jane E., Gebski, Val and Janda, Monika (2016). Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy. Gynecologic Oncology Research and Practice, 3 (1), 1. doi: 10.1186/s40661-016-0023-8

Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy

2014

Journal Article

Epigenetic regulation in cancer progression

Baxter, Eva, Windloch, Karolina, Gannon, Frank and Lee, Jason S. (2014). Epigenetic regulation in cancer progression. Cell & Bioscience, 4 (1) 45, 45. doi: 10.1186/2045-3701-4-45

Epigenetic regulation in cancer progression